NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 56 filers reported holding NUVALENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,632,526 | +108910.7% | 1,210,192 | 0.0% | 2.96% | +25.1% |
Q2 2023 | $51,034 | +61.6% | 1,210,192 | 0.0% | 2.37% | +52.6% |
Q1 2023 | $31,574 | -99.9% | 1,210,192 | 0.0% | 1.55% | -18.4% |
Q4 2022 | $36,039,518 | +53.2% | 1,210,192 | 0.0% | 1.90% | +43.6% |
Q3 2022 | $23,526,000 | +43.4% | 1,210,192 | 0.0% | 1.32% | +27.3% |
Q2 2022 | $16,410,000 | -2.4% | 1,210,192 | 0.0% | 1.04% | +20.3% |
Q1 2022 | $16,810,000 | -27.0% | 1,210,192 | 0.0% | 0.86% | -3.5% |
Q4 2021 | $23,042,000 | -15.6% | 1,210,192 | 0.0% | 0.90% | -6.1% |
Q3 2021 | $27,290,000 | – | 1,210,192 | – | 0.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,788,981 | $83,055,854 | 13.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $595,332,695 | 12.32% |
Bain Capital Life Sciences Investors, LLC | 3,577,267 | $106,531 | 11.90% |
COMMODORE CAPITAL LP | 913,621 | $27,208 | 4.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 302,963 | $9,022,238 | 2.58% |
Boxer Capital, LLC | 1,210,192 | $36,039,518 | 1.90% |
Perceptive Advisors | 2,255,007 | $67,154,108 | 1.89% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,673,214 | $49,828,313 | 0.74% |
Avoro Capital Advisors LLC | 1,555,555 | $46,324,428 | 0.69% |
AlphaCentric Advisors LLC | 15,500 | $461,590 | 0.46% |